Article Details

Portage Biotech Presents Updated Data on the Phase 1/2 Trial Evaluating PORT ... - MarketScreener

Retrieved on: 2022-11-10 20:15:07

Tags for this article:

Click the tags to see associated articles and topics

Portage Biotech Presents Updated Data on the Phase 1/2 Trial Evaluating PORT ... - MarketScreener. View article details on hiswai:

Excerpt

We see that monotherapy treatment with iNKT agonists shows a heightened immune response and better cancer control in animal models that are resistant ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up